Cholesterol Disorders

 
PREVIEW of AHA 2020 Scientific Sessions: Late-breaking Science, Days 4 and 5
November 10, 2020

Preview days 4 and 5 of the American Heart Association 2020 live late-breaking science sessions. Decide what you need to watch and when.

AHA 2020 Scientific Sessions Preview: Late-breaking Science, Days 1, 2 and 3
November 10, 2020

What to watch during the AHA 2020 late-breaking science sessions? We break down the first 3 days of clinical trial presentations for you, here.

CLINICAL FOCUS COLLECTION: Preventive Cardiology
November 04, 2020

Preventive Cardiology Collection Table of Contents: Expert video interviews, short, clinical guideline-focused quizzes, facts at-a-glance slideshows, plus news.

Dangerous CV Drug-Drug Interactions: A 5-question Quiz
October 23, 2020

Cardiovascular medications are widely-prescribed in the US. Alex Evans, PharmD, MBA, drafted questions on the top 5 dangerous interactions he sees regularly in practice.

Expert Update on Lp(a): Dr Patrick Moriarty Explains the Next CVD Target
October 21, 2020

Elevated lipoprotein A is a genetically determined independent risk factor for CVD, affecting up to 30% of the population. Phase 3 trials for the first treatment are underway.

Primary Care Can Lead in CVD Prevention
August 24, 2020

VIDEO: Preventive cardiology is a multidisciplinary therapeutic area and primary care clinicians have the advantage of greatest patient exposure to help advance care.

VIDEO: Preventive Cardiology in 2020: Room for Improvement
August 20, 2020

VIDEO: Treatment for ASCVD patients at high risk is lagging behind the availability of powerful new therapies. And, the pandemic does not help, according to Seth Baum, MD.

9 Questions on Primary CV Disease Prevention
March 02, 2020

The 2019 ACC/AHA guidelines on the primary prevention of cardiovascular disease could change your clinical practice. Try these 9 questions to find out how.

First Oral Non-Statin LDL-C Lowering Drug Approved in 2 Decades
February 25, 2020

Bempedoic acid is the first oral, once-daily, non-statin cholesterol lowering medication to receive FDA approval since 2002.

AHA/ACC & ESC/EAS Lipid Guidelines: Compare & Contrast Quiz
January 10, 2020

Dyslipidemia guidelines from the US and Europe take slightly different routes to similar ends. Test your knowledge of the twists and turns.